An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report)

Background. Personalized therapy is becoming increasingly popular in oncological scenarios, not only based on molecular pharmacological targets, but also preventing any drug–drug–gene interaction (DDGI), which could lead to severe toxicities. Single nucleotide polymorphisms (SNPs), the individual ge...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Martina Panebianco, Beatrice Taurelli Salimbeni, Michela Roberto, Paolo Marchetti
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-05-01
Colecção:	Current Oncology
Assuntos:	hormone receptor positive (HR+) HER2+ breast cancer drug-drug-gene interaction (DDGI) single nucleotide polymorphisms (SNPs)
Acesso em linha:	https://www.mdpi.com/1718-7729/28/3/184
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!